Protalix BioTherapeutics (PLX) Liabilities from Discontinued Operations (2014 - 2016)

Protalix BioTherapeutics' Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 293000.0 for Q2 2016.

• In Q2 2016, Liabilities from Discontinued Operations changed N/A year-over-year to 293000.0; the TTM figure through Jun 2016 stood at 293000.0 (changed N/A YoY), while the FY2015 annual figure was 1568000.0, down 97.03% from the prior year.
• Liabilities from Discontinued Operations was 293000.0 for Q2 2016 at Protalix BioTherapeutics, up from 128000.0 in the prior quarter.
• In the past five years, Liabilities from Discontinued Operations ranged from a high of 52830000.0 in Q4 2014 to a low of 128000.0 in Q1 2016.
• Historically, Liabilities from Discontinued Operations has averaged 13704750.0 across 3 years, with a median of 930500.0 in 2015.
• Biggest YoY gain for Liabilities from Discontinued Operations was 97.03% in 2015; the steepest drop was 97.03% in 2015.
• A 3-year view of Liabilities from Discontinued Operations shows it stood at 52830000.0 in 2014, then plunged by 97.03% to 1568000.0 in 2015, then tumbled by 81.31% to 293000.0 in 2016.
• The last three Liabilities from Discontinued Operations figures came in at 293000.0 (Q2 2016), 128000.0 (Q1 2016), and 1568000.0 (Q4 2015), per Business Quant data.